In the past year, Rainbow Coral Corp. has aggressively pursued relationships with researchers, scientists and other professionals throughout the biotech industry; yesterday, the company announced that it is in the process of becoming a member of BioHouston, a prominent life science research group.
The company expects the partnership to provide innumerable opportunities to connect with investors and researchers alike. Annually, BioHouston hosts over 80 networking events where attendees typically include academic and research institutions as well as life science companies. With over $1.8 billion in annual academic research investments and over 160 life science companies, Houston, TX attracts venture capitalists from across the nation to invest in the growing life science industry.
Patrick Brown, President and CEO of RBCC, remarked, “It’s critical that information sharing be at the forefront of how we operate and develop effective medical treatments. The BioHouston community will give us the opportunity to develop relationships with other experts in the field and ultimately, develop new, potentially life-saving treatments.”
Through its biotech division, Rainbow BioSciences, RBCC is working to develop new medical and research technology innovations to compete alongside companies such as Cell Therapeutics, Inc. (NASDAQ: CTIC), Biogen Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) and Elan Corp. (NYSE: ELN).
For more information on Rainbow BioSciences’ biotechnology initiative, please visit www.rainbowbiosciences.com
Let us hear your thoughts below: